+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urinary Tract Infection Drug"

Urinary Tract Infection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Urinary Tract Infection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 184 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
From
From
From
From
From
Methenamine API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Methenamine API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Levofloxacin HCl Market - Global Forecast to 2030 - Product Thumbnail Image

Levofloxacin HCl Market - Global Forecast to 2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Acetohydroxamic Acid Market - Global Forecast 2025-2030 - Product Thumbnail Image

Acetohydroxamic Acid Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Ceftazidime Dihydrochloride Market - Global Forecast 2025-2030 - Product Thumbnail Image

Ceftazidime Dihydrochloride Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Loading Indicator

The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs. The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more